FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称MAGROLIMAB
异名/同义词ANTI-CD47 MONOCLONAL ANTIBODY HU5F9-G4
HU5F9-G4
IMMUNOGLOBULIN G4(225-PROLINE), ANTI-(HUMAN CD47 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL HU5F9-G4 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HU5F9-G4 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS CD47 (INTEGRIN ASSOCIATED PROTEIN, IAP, MER6, OA3)), MONOCLONAL ANTIBODYGAMMA4 HEAVY CHAIN (1-444) (VH (HOMO SAPIENS IGHV1-3*01 (87.8%)-(IGHD)-IGHJ4*01 (100%)) (8.8.10) (1-117)-HOMO SAPIENS IGHG4*01 (CH1 (118-215), HINGE S10>P (225) (216-227), CH2 (228-337), CH3 (338-442), CHS (443-444)) (118-444)), (131-219')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-219') (V-KAPPA (MUS MUSCULUS IGKV1-117*01 (89.0%)-IGKJ2*03 (91.7%)/HOMO SAPIENS IGKV2-28*01 (86%)-IGKJ2*01 (100%)) (11.3.9) (1'-112')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (158), V101 (196) (113'-219'))DIMER (223-223'':226-226'')-BISDISULFIDE
MAGROLIMAB
MAGROLIMAB [INN]
MAGROLIMAB [USAN]
MAGROLIMAB [WHO-DD]
CAS登记号2169232-81-7
物质唯一标识(Unique Ingredient Identifier)90YIEHRFJ9
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System